학술논문

Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: Results from a phase 2b, randomized, controlled trial
Document Type
Article
Source
In: Journal of the European Academy of Dermatology and Venereology. (Journal of the European Academy of Dermatology and Venereology, December 2023, 37(12):2558-2568)
Subject
Language
English
ISSN
14683083
09269959